Ellevest, Inc. Exact Sciences Corp Transaction History

Ellevest, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$47.19 - $70.77 $3,067 - $4,600	65 Added 11.65%	623 $42,000
Q4 2022 Feb 03, 2023	SELL	$30.35 - $53.15 $2,792 - $4,889	-92 Reduced 14.15%	558 $27,000
Q3 2022 Nov 02, 2022	SELL	$31.97 - $49.37 $1,023 - $1,579	-32 Reduced 4.69%	650 $21,000
Q2 2022 Jul 18, 2022	BUY	$35.61 - $76.23 $12,356 - $26,451	347 Added 103.58%	682 $27,000
Q1 2022 Apr 19, 2022	BUY	$57.56 - $82.54 $13,584 - $19,479	236 Added 238.38%	335 $23,000
Q4 2021 Jan 24, 2022	BUY	$72.5 - $100.68 $4,422 - $6,141	61 Added 160.53%	99 $8,000
Q3 2021 Oct 19, 2021	SELL	$90.24 - $124.05 $1,082 - $1,488	-12 Reduced 24.0%	38 $4,000
Q2 2021 Jul 13, 2021	SELL	$93.66 - $139.27 $8,710 - $12,952	-93 Reduced 65.03%	50 $6,000
Q1 2021 May 03, 2021	SELL	$116.57 - $155.01 $815 - $1,085	-7 Reduced 4.67%	143 $19,000
Q4 2020 Feb 04, 2021	BUY	$99.61 - $142.12 $14,941 - $21,318	150 New	150 $20,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.